R M Mackie

Author PubWeight™ 63.91‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Systemic complement activation in psoriasis vulgaris. Clin Exp Dermatol 1996 1.94
2 Tanning with ultraviolet A sunbeds. BMJ 1990 1.93
3 Postoperative depression of tumour-directed cell-mediated immunity in patients with malignant disease. Br Med J 1972 1.84
4 Juvenile plantar dermatosis: a new entity?. Clin Exp Dermatol 1976 1.51
5 Assessment of an anti-T-cell receptor variable region antibody panel in cutaneous T-cell lymphoma. Br J Dermatol 1994 1.39
6 The suitability of SunCheck patches and Tanscan cards for monitoring the sunburning effectiveness of sunlight. Br J Dermatol 1993 1.38
7 Health and the ozone layer. BMJ 1988 1.37
8 UVA-induced melanocytic lesions. Br J Dermatol 1987 1.35
9 Use of NK1 C3 monoclonal antibody in the assessment of benign and malignant melanocytic lesions. J Clin Pathol 1984 1.14
10 Site-specific melanocytic naevus counts as predictors of whole body naevi. Br J Dermatol 1988 1.09
11 Assessment of prognosis in patients with malignant melanoma. Lancet 1972 1.05
12 Point mutations in the N-ras oncogene in malignant melanoma and congenital naevi. Br J Dermatol 1994 1.04
13 Assessment of a contact-plate sampling technique and subsequent quantitative bacterial studies in atopic dermatitis. Br J Dermatol 1990 1.04
14 Association of MC1R variants and host phenotypes with melanoma risk in CDKN2A mutation carriers: a GenoMEL study. J Natl Cancer Inst 2010 1.04
15 Clinical accuracy of the diagnosis of cutaneous malignant melanoma. Br J Dermatol 1998 1.03
16 Cell-mediated immunity in patients with malignant melanoma. Br J Dermatol 1972 0.99
17 Loss of beta2 microglobulin from the cell surface of cutaneous malignant and premalignant lesions. Br J Dermatol 1981 0.98
18 Sensitization to tumour-associated antigens in human breast carcinoma. Int J Cancer 1974 0.97
19 Seven-point checklist for melanoma. Clin Exp Dermatol 1991 0.96
20 The spectrum of mutations in erythrokeratodermias--novel and de novo mutations in GJB3. Hum Genet 2000 0.93
21 Adjuvant interferon alpha 2b in high risk melanoma - the Scottish study. Br J Cancer 2001 0.93
22 An immunohistochemical study of androgen, oestrogen and progesterone receptors in the vulva and vagina. Br J Obstet Gynaecol 1998 0.92
23 Severe reaction to diphosphonate: implications for treatment of Paget's disease. BMJ 1988 0.89
24 Leukocyte migration inhibition by cancer patients' sera. Int J Cancer 1976 0.89
25 Serum anti-tumour antibodies and auto-antibodies in vitiligo. Br J Dermatol 1975 0.88
26 The prescription of isotretinoin to women: is every precaution taken? Br J Dermatol 1998 0.88
27 Tioconazole nail solution--an open study of its efficacy in onychomycosis. Clin Exp Dermatol 1985 0.87
28 Comparison of photodynamic therapy with cryotherapy in the treatment of Bowen's disease. Br J Dermatol 1996 0.87
29 Plantar malignant melanoma in a white Caucasian population. Br J Dermatol 1993 0.87
30 Letter: Formalin-fixed tumour cells in the leukocyte migration test. Lancet 1973 0.86
31 An audit of the completeness of non-melanoma skin cancer registration in Greater Glasgow. Br J Dermatol 1997 0.86
32 Lupus erythematosus in association with finger-clubbing. Br J Dermatol 1973 0.85
33 An assessment of the diagnostic value of the monoclonal antibodies Leu 8, OKT9, OKT10 and Ki67 in cutaneous lymphocytic infiltrates. Br J Dermatol 1986 0.85
34 Pustular psoriasis in association with renal amyloidosis. Br J Dermatol 1974 0.85
35 The effect of treatment with 13-cis-retinoic acid on the metabolic burst of peripheral blood neutrophils from patients with acne. Br J Dermatol 1991 0.85
36 Natural-killer-cell activity in atopic dermatitis. Clin Allergy 1984 0.83
37 The relationship between immunological parameters and response to therapy in resistant oral candidosis. Br J Dermatol 1978 0.83
38 Formalinized tumour cells in the leucocyte migration inhibition test. Clin Exp Immunol 1975 0.83
39 Staphylococcus aureus and intra-nasal mupirocin in patients receiving isotretinoin for acne. Br J Dermatol 1992 0.82
40 Plasma zinc in psoriatic in-patients treated with local zinc applications. Br J Dermatol 1980 0.81
41 The use of a double-label immunoperoxidase monoclonal antibody technique in the investigation of patients with mycosis fungoides. Br J Dermatol 1982 0.80
42 A multicentre phase II trial of vindesine in malignant melanoma. Eur J Cancer Clin Oncol 1982 0.80
43 Tumor-directed cellular immunity in malignant melanoma and its modification by surgical treatment. Yale J Biol Med 1973 0.80
44 Indirect leukocyte migration assay in patients with malignant melanoma. Int J Cancer 1979 0.80
45 An examination of the immunology of cancer patients. Int J Cancer 1976 0.79
46 The contribution of direct immunofluorescence to the diagnosis of lupus erythematosus. J Cutan Pathol 1989 0.79
47 Keratinocyte expression of intercellular adhesion molecule 1 (ICAM-1) correlated with infiltration of lymphocyte function associated antigen 1 (LFA-1) positive cells in evolving allergic contact dermatitis reactions. Histopathology 1991 0.79
48 Human melanoma cell-derived factor(s) stimulate fibroblast glycosaminoglycan synthesis. Int J Cancer 1992 0.79
49 The effect of topical steroid application on natural killer cell activity. Clin Exp Allergy 1989 0.79
50 The role of sunlight in the aetiology of cutaneous malignant melanoma. Clin Exp Dermatol 1981 0.79
51 Localization of transforming growth factor-alpha RNA and protein in the skin of psoriatic patients receiving therapy. Br J Dermatol 1994 0.79
52 In vitro reaction of cancer patients and others to Bacillus Calmette-Gueérin. Int J Cancer 1980 0.79
53 The unexpected sites of melanoma regional recurrences. J Plast Reconstr Aesthet Surg 2006 0.79
54 Personal solar UV-A doses received by patients undergoing oral psoralen photochemotherapy for psoriasis. Br J Dermatol 1981 0.79
55 The use of paraffin-processed tissue and the immunoperoxidase technique in the diagnosis of bullous diseases, lupus erythematosus and vasculitis. Br J Dermatol 1982 0.78
56 A case of pagetoid reticulosis bearing the T cytotoxic suppressor surface marker on the lymphoid infiltrate: further evidence that pagetoid reticulosis is not a variant of mycosis fungoides. Br J Dermatol 1984 0.78
57 Follicular mucinosis, mycosis fungoides, and acute myeloid leukemia. J Clin Pathol 1990 0.78
58 The relationship between risk of death from clinical stage 1 cutaneous melanoma and thickness of primary tumour: no evidence for steps in risk. Scottish Melanoma Group. Br J Cancer 1991 0.78
59 Novel variants of human papillomavirus type 2 in warts from immunocompromised individuals. Br J Dermatol 1989 0.78
60 Cellular immunity in human malignant melanoma and melanoma histology. Br J Cancer 1973 0.77
61 Pyoderma gangrenosum in infancy. Acta Derm Venereol 1982 0.77
62 A quantitative analysis of the Langerhans cell in chronic plaque psoriasis. Clin Exp Dermatol 1986 0.77
63 Intraoperative identification of sentinel lymph node in patients with malignant melanoma. Br J Cancer 1997 0.77
64 Retinoic acid-induced inhibition of metastatic melanoma cell lung colonization and adhesion to endothelium and subendothelial extracellular matrix. Clin Exp Metastasis 1992 0.77
65 Out-patient treatment of psoriasis: short contact and overnight dithranol therapy compared. Br J Dermatol 1985 0.76
66 Cellular immunity to breast carcinoma and malignant melanoma. Br J Cancer Suppl 1973 0.75
67 The melanoma epidemic. Excess exposure to ultraviolet light is established as major risk factor. BMJ 1996 0.75
68 Comparative study of three methods of plastic embedding in diagnostic dermatopathology. J Clin Pathol 1985 0.75
69 Management of cutaneous T cell lymphoma. BMJ 1994 0.75
70 Not wanted at thirty-five. Lancet 1979 0.75
71 Porphyria cutanea tarda and hyperkeratosis. Br J Clin Pract 1972 0.75
72 Proceedings: Some aspects of the use of B.C.G. in the treatment of advanced malignant disease. Br J Cancer 1974 0.75
73 Proceedings: cellular immunity to malignant melanoma. Br J Surg 1973 0.75
74 Onycholysis occurring during PUVA therapy. Clin Exp Dermatol 1979 0.75
75 The suitability of sunglasses used by patients following ingestion of psoralen. Br J Dermatol 1988 0.75
76 Localized secondary telangiectasia in patients with thyroid disease. Br J Dermatol 1973 0.75
77 Cutaneous lymphadenoma: a case report and review of the literature. Br J Dermatol 1993 0.75
78 Distribution of T cell subsets and Langerhans cells in mycosis fungoides, and the effect of PUVA therapy. Clin Exp Dermatol 1986 0.75
79 Wiskott-Aldrich syndrome with partial response to transfer factor. Br J Dermatol 1978 0.75
80 Generalized eruptive histiocytoma. Br J Dermatol 1992 0.75
81 Perspectives in dermatology: Great Britain (1972-1974). Int J Dermatol 1975 0.75
82 Ultraviolet B radiation was increased at ground level in scotland during a period of ozone depletion. Br J Dermatol 1997 0.75
83 The labial melanotic macule: a review of 79 cases. Br J Dermatol 1997 0.75
84 Further evidence of the safety of tar in the management of psoriasis. Br J Dermatol 1985 0.75
85 The mechanism of tumour cell induced inhibition of human leucocyte migration. Eur J Cancer 1979 0.75
86 Topical econazole in cutaneous fungal infections. Practitioner 1980 0.75
87 Ground-level solar spectral irradiance in Glasgow: an inter-comparison of two sites. Photodermatol Photoimmunol Photomed 2004 0.75
88 Malignant melanoma and the Scottish Melanoma Group. Health Bull (Edinb) 1986 0.75
89 Malignant melanomata: an aid to preoperative diagnosis. Br J Surg 1972 0.75
90 The management of cutaneous malignant melanoma. Clin Exp Dermatol 1982 0.75
91 Histological changes observed in the skin of patients with mycosis fungoides receiving photochemotherapy. Clin Exp Dermatol 1980 0.75
92 Cutaneous and ocular side-effects of oral photochemotherapy: results of an 8-year follow-up study. Br J Dermatol 1987 0.75
93 The immune response in human malignant melanoma. Clin Exp Dermatol 1976 0.75
94 Proceedings: Immunity in patients with breast cancer. Br J Cancer 1975 0.75
95 Evaluation and staging in the Scottish Dermatological Society mycosis fungoides register. Bull Cancer 1977 0.75
96 Re-examining crude coal tar treatment for psoriasis. Br J Dermatol 1992 0.75
97 A case of focal dermal hypoplasia. Clin Exp Dermatol 1982 0.75
98 Allergic and irritant contact dermatitis compared in the treatment of alopecia totalis and universalis. A comparison of the value of topical diphencyprone and tretinoin gel. Br J Dermatol 1989 0.75
99 Etretinate and visual function: a 1-year follow-up study. Br J Dermatol 1991 0.75
100 Studies in cutaneous immunofluorescence. I. The effect of storage time on direct immunofluorescence of skin biopsies from bullous disease and lupus erythematosus. J Cutan Pathol 1980 0.75
101 Current trends in the management of recurrent malignant melanoma. Clin Exp Dermatol 1977 0.75
102 Immunological changes in cancer patients receiving BCG. Dev Biol Stand 1978 0.75
103 Single-centre prospective study of isolated limb perfusion with melphalan in the treatment of subungual malignant melanoma. Br J Surg 1995 0.75
104 Juvenile plantar dermatosis--an 8-year follow-up of 102 patients. Clin Exp Dermatol 1987 0.75